180 Life Sciences Poised to Break Ground with Anti-TNF Program

180 Life Sciences Poised to Break Ground with Anti-TNF Program

Source: 
BioSpace
snippet: 

Despite a storied career in drug design that has spanned multiple decades, James Woody believes there is still a significant amount of work left to be accomplished with the development of tumor necrosis factor (TNF) inhibitor biologics.